Caricamento...
Rasagiline and Rapid Symptomatic Motor Effect in Parkinson’s Disease: Review of Literature
Rasagiline is a monoamine oxidase type-B inhibitor used as monotherapy or in addition to levodopa in the treatment of Parkinson’s disease. Once daily administration of rasagiline makes it easy to use, and allows good compliance by patients and adherence to therapy. Several multicenter studies have n...
Salvato in:
| Pubblicato in: | Neurol Ther |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer Healthcare
2013
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4381918/ https://ncbi.nlm.nih.gov/pubmed/26000219 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40120-013-0014-1 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|